The percentages and absolute numbers of CD25-expressing T cells (CD4+CD25+) and CD25-expressing B cells (B220+CD25+) in T-LPLs were drastically higher in the MLN of the IL-33-treated chronic colitis group than that of the control group (Figures 5(a) and 6(a)). The gene discussed is IL33; the disease is Chronic colitis.